TrialCancer chemotherapy and pharmacology2023

Rituximab biosimilar for the treatment of diffuse large B-cell lymphoma: a phase 3 randomized study in India.

Ankit Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.